122 related articles for article (PubMed ID: 11512190)
1. [Genetic-epidemiological studies of apolipoprotein(a) polymorphism and its significance in nephrological diseases and type I diabetes mellitus].
Kronenberg F; Auinger M; Dieplinger H
Acta Med Austriaca; 1999; 26(5):142-7. PubMed ID: 11512190
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM.
Kimura H; Suzuki Y; Gejyo F; Karasawa R; Miyazaki R; Suzuki S; Arakawa M
Am J Kidney Dis; 1998 Apr; 31(4):666-73. PubMed ID: 9531184
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein(a) phenotypes and lipoprotein(a) in type 1 diabetes mellitus patients and their first-degree relatives.
Cardoso-Saldaña G; Bravo-Rios LE; Torres-Tamayo M; Zamora-González J; Posadas-Romero C
Rev Invest Clin; 2003; 55(6):662-9. PubMed ID: 15011736
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein (a) concentration and apolipoprotein (a) phenotype in subjects with type 2 diabetes mellitus.
Shi H; Fang J; Yang X; Shen Z; Zhu X
Chin Med J (Engl); 1998 Nov; 111(11):1013-7. PubMed ID: 11189206
[TBL] [Abstract][Full Text] [Related]
5. Serum lipoprotein(a) concentration in patients with chronic renal failure receiving haemodialysis: influence of apolipoprotein (a) genetic polymorphism.
Auguet T; Sentí M; Rubiés-Prat J; Pelegrí A; Pedro-Botet J; Nogués X; Romero R
Nephrol Dial Transplant; 1993; 8(10):1099-103. PubMed ID: 8272223
[TBL] [Abstract][Full Text] [Related]
6. ACE gene polymorphism, left ventricular geometry, and mortality in diabetic patients with end-stage renal disease.
Sakka Y; Babazono T; Sato A; Ujihara N; Iwamoto Y
Diabetes Res Clin Pract; 2004 Apr; 64(1):41-9. PubMed ID: 15036826
[TBL] [Abstract][Full Text] [Related]
7. Total plasma homocysteine is associated with hypertension in Type I diabetic patients.
Neugebauer S; Tarnow L; Stehouwer C; Teerlink T; Baba T; Watanabe T; Parving HH
Diabetologia; 2002 Sep; 45(9):1315-24. PubMed ID: 12242465
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort.
Klein RL; McHenry MB; Lok KH; Hunter SJ; Le NA; Jenkins AJ; Zheng D; Semler A; Page G; Brown WV; Lyons TJ; Garvey WT;
J Diabetes Complications; 2005; 19(1):18-25. PubMed ID: 15642486
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein a polymorphism predicts lipoprotein a concentration in renal transplant recipients.
Argani H; Ghorbanihaghjo A; Rashtchizadeh N; Rahbaninobar M
Transplant Proc; 2005 Sep; 37(7):2925-8. PubMed ID: 16213263
[TBL] [Abstract][Full Text] [Related]
10. Association of serum apolipoprotein C III levels and apolipoprotein C III gene Sst I polymorphism with carotid intima-media thickness in Chinese type 2 diabetic patients.
Chen X; Tian H; Liu R
Diabetes Res Clin Pract; 2004 Oct; 66(1):41-7. PubMed ID: 15364160
[TBL] [Abstract][Full Text] [Related]
11. The 20210 G to A prothrombin polymorphism and late complications in type 1 diabetes mellitus.
Humpert PM; Isermann B; Rudofsky G; Ziegler R; Bierhaus A; Ritz E; Nawroth PP
Thromb Haemost; 1999 Jan; 81(1):164. PubMed ID: 10348712
[No Abstract] [Full Text] [Related]
12. Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients.
Arikan H; Koc M; Sari H; Tuglular S; Ozener C; Akoglu E
Ren Fail; 2007; 29(6):713-9. PubMed ID: 17763167
[TBL] [Abstract][Full Text] [Related]
13. Improved survival in patients with type 1 diabetes mellitus after renal transplantation compared with hemodialysis: a case-control study.
Brunkhorst R; Lufft V; Dannenberg B; Kliem V; Tusch G; Pichlmayr R
Transplantation; 2003 Jul; 76(1):115-9. PubMed ID: 12865796
[TBL] [Abstract][Full Text] [Related]
14. Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan.
Hsieh MC; Lin SR; Yang YC; Chen HC; Lin JN; Shin SJ
J Nephrol; 2002; 15(4):368-73. PubMed ID: 12243365
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein(a) polymorphism and its association with plasma lipoprotein(a) levels: a north Indian study.
Vasisht S; Gulati R; Srivastava LM; Narang R; Chopra V; Srivastava N; Agarwal DP; Manchanda SC
Indian Heart J; 2000; 52(2):165-70. PubMed ID: 10893891
[TBL] [Abstract][Full Text] [Related]
16. Haptoglobin phenotype and vascular complications in patients with diabetes.
Levy AP; Roguin A; Hochberg I; Herer P; Marsh S; Nakhoul FM; Skorecki K
N Engl J Med; 2000 Sep; 343(13):969-70. PubMed ID: 11012324
[No Abstract] [Full Text] [Related]
17. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients.
Maeda M; Yamamoto I; Fukuda M; Motomura T; Nishida M; Nonen S; Fujio Y; Kasayama S; Azuma J
J Diabetes Complications; 2008; 22(2):119-25. PubMed ID: 18280442
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein(a) phenotypes and their predictive value for coronary heart disease: identification of an operative cut-off of apolipoprotein(a) polymorphism.
Gazzaruso C; Garzaniti A; Buscaglia P; Bonetti G; Falcone C; Fratino P; Finardi G; Geroldi D
J Cardiovasc Risk; 1998 Feb; 5(1):37-42. PubMed ID: 9816554
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein(a) and atherosclerotic disease in insulin-dependent diabetic patients with declining glomerular filtration rate.
Earle KA; Mattock M; Morocutti A; Aravanitis D; Viberti GC
Diabet Med; 1996 Dec; 13(12):1071-2. PubMed ID: 8973890
[No Abstract] [Full Text] [Related]
20. Type 2 diabetes in patients with end-stage renal disease is not associated with further increased serum inflammatory parameters.
Bodlaj G; Berg J; Pichler R; Sailer T; Biesenbach G
J Nephrol; 2004; 17(1):112-7. PubMed ID: 15151267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
